Podcast Episodes

Back to Search
387: Challenges for a crucial sickle cell treatment and the latest outlook for GLP-1s

On this week’s episode of The Readout LOUD: two starkly different financial outlooks from Novo Nordisk and Eli Lilly, a psychedelics drug from Compas…

8 months, 2 weeks ago

Short Long
View Episode
From Drug Story: Lipitor and Heart Disease
From Drug Story: Lipitor and Heart Disease

This is an episode of Drug Story, a podcast by Thomas Goetz. You can find the rest of the series at https://www.drugstory.co/podcast

Once you turn 40…

8 months, 2 weeks ago

Short Long
View Episode
386: The high stakes for Huntington's patients

Biotech company UniQure is set to meet with the Food and Drug Administration to discuss the path forward for its gene therapy for Huntington's diseas…

8 months, 2 weeks ago

Short Long
View Episode
385: A measles outbreak and hospitals' financial troubles

Why is the U.S. at risk of losing its measles elimination status? How are health officials reacting to the measles outbreak? And what did top Centers…

8 months, 3 weeks ago

Short Long
View Episode
384: Live from the JP Morgan conference, a sit-down with Novo Nordisk's CEO and VC Bob Nelsen

For this very special episode of The Readout LOUD Allison, Adam, and Elaine are live from the J.P. Morgan Healthcare Conference in San Francisco.

The…

9 months ago

Short Long
View Episode
383: JPM to bring more deals and happy CEOs

What news happened over the holidays? Why will pharma CEOs be greeted warmly in San Francisco next week? And who will buy Revolution Medicines?


We di…

9 months, 1 week ago

Short Long
View Episode
382: Biotech's year in review

Is the biotech industry truly out of its slump? Why are employers dropping coverage of weight loss drugs? And what will the hosts bake for the holida…

10 months ago

Short Long
View Episode
381: The future of American science and a dispatch from ASH

How did Terns Pharmaceuticals and its “hodgepodge” pipeline grab attention at the American Society of Hematology conference? Is Eli Lilly’s new drug …

10 months, 1 week ago

Short Long
View Episode
380: A new top drug regulator and the future of psychedelics

On this week’s episode of "The Readout Loud": a look at an emerging class of psychedelic drugs that may treat depression, anxiety, and other psychiat…

10 months, 2 weeks ago

Short Long
View Episode
379: How Mark Cuban plans to ‘f— up’ health care

How much time does Mark Cuban spend thinking about health care? Why does he think TrumpRx, a direct drug purchasing platform that the Trump administr…

10 months, 4 weeks ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us